Evidence map›Paper›PMID 37505307›Full record

ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2024

Three stilbenes from pigeon pea with promising anti-methicillin-resistant Staphylococcus aureus biofilm formation activity.

Bai-Lin Li, Jia-Yan Chen, Juan-Juan Hu, Yu-Wen Fan, Zhuo-Yi Ao, Wei-Jie Zhang, Xin Lian, Hui-Jun Liang, Qian-Ran Li, Xiao-Xian Guan and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Improved Bioavailability of Stilbenes fromMolecules (Basel, Switzerland) · 2025
    Article
  3. Diterpenoids from Isodon serra with promising anti-MRSA activities.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Bai-Lin Li *School of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Jia-Yan Chen *School of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Juan-Juan HuLaboratory for Functional Foods and Human Health, Center for Excellence in Post-Harvest Technologies, North Carolina Agricultural and Technical State University, Kannapolis, NC, 28081, USA.
Yu-Wen FanSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Zhuo-Yi AoSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Wei-Jie ZhangSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Xin LianSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Hui-Jun LiangSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Qian-Ran LiSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Xiao-Xian GuanSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Jie-Wei WuSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Jie YuanSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China. yuanjie@gzucm.edu.cn.
Dong-Xu JiangSchool of Pharmaceutical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China.
Guangzhou University of Chinese Medicine · CNNorth Carolina Agricultural and Technical State University · USSouth China Botanical Garden · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cajaninstilbene acid (CSA), longistylin A (LLA), and longistylin C (LLC) are three characteristic stilbenes isolated from pigeon pea. The objective of this study was to evaluate the antibacterial activity of these stilbenes against Staphylococcus aureus and even methicillin-resistant Staphylococcus aureus (MRSA) and test the possibility of inhibiting biofilm formation. The minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of these stilbenes were evaluated. And the results showed that LLA was most effective against tested strains with MIC and MBC values of 1.56 μg/mL followed by LLC with MIC and MBC values of 3.12 μg/mL and 6.25 μg/mL as well as CSA with MIC and MBC values of 6.25 μg/mL and 6.25-12.5 μg/mL. Through growth curve and cytotoxicity analysis, the concentrations of these stilbenes were determined to be set at their respective 1/4 MIC in the follow-up research. In an anti-biofilm formation assay, these stilbenes were found to be effectively inhibited bacterial proliferation, biofilm formation, and key gene expressions related to the adhesion and virulence of MRSA. It is the first time that the anti-S. aureus and MRSA activities of the three stilbenes have been systematically reported. Conclusively, these findings provide insight into the anti-MRSA mechanism of stilbenes from pigeon pea, indicating these compounds may be used as antimicrobial agents or additives for food with health functions, and contribute to the development as well as application of pigeon pea in food science.

Indexed as

CajanusMethicillin-Resistant Staphylococcus aureusStilbenesAnti-Bacterial AgentsAntibodiesBiofilmsMicrobial Sensitivity TestsAnti-Bacterial AgentsAntibodiesStilbenesAntibacterial activitiesBiofilmMethicillin-resistant Staphylococcus aureusPigeon peaStilbene

Identifiers

PMID37505307
OpenAlexW4385330900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.